VOC Profiles of Saliva in Assessment of Halitosis and Submandibular Abscesses Using HS-SPME-GC/MS Technique.

Halitosis and submandibular abscesses are examples of mouth-related diseases with the possible bacterial origin. Salivary volatile organic compounds (VOCs) are potential biomarkers of them, once they can be addressed as metabolites of bacterial activity. Healthy patients (n = 15), subjects with submandibular abscesses located in fascial deep space (n = 10), and subjects with halitosis (n = 5) were enrolled in the study. Saliva samples were subjected to headspace solid-phase microextraction (HS-SPME) and gas chromatography coupled to mass spectrometry (GC/MS) analysis. A total number of 164 VOCs was detected by the developed methodology, 23 specific for halitosis and 41 for abscess. Halitosis' profiles were characterized by a larger number of sulfur compounds, while for abscess they had a higher variety of alcohols, aldehydes, and hydrocarbons-biomarkers of inflammatory processes. Principal components analysis allowed visualization of clusters formed according to the evaluated conditions. Kruskal-Wallis test indicated that 39 VOCs presented differentiated responses between the studied groups, with statistical relevance (p < 0.05). Random forest was applied, and a prediction model based on eight VOCs (2-butanone, methyl thioacetate, 2-methylbutanoic acid, S-methyl pentanethioate, dimethyl tetrasulfide, indolizine, pentadecane, and octadecanal) provided 100% of sensitivity, 82% of specificity, and 91% of balanced accuracy, indicating the specific presence of submandibular abscess.

Systemic effects of H2S inhalation at human equivalent dose of pathologic halitosis on rats.

OBJECTIVES: Halitosis is composed by hundreds of toxic gases. It is still not clear whether halitosis gases self-inhaled by halitosis patients cause side effects. The aim of the study was to investigate the effect of H2S inhalation at a low concentration (human equivalent dose of pathologic halitosis) on rats. MATERIALS AND METHODS: The threshold level of pathologic halitosis perceived by humans at 250 ppb of H2S was converted to rat equivalent concentration (4.15 ppm). In the experimental group, 8 rats were exposed to H2S via continuous inhalation but not the control rats. After 50 days, blood parameters were measured and tissue samples were obtained from the brain, kidney and liver and examined histopathologically to determine any systemic effect. RESULTS: While aspartate transaminase, creatine kinase-MB and lactate dehydrogenase levels were found to be significantly elevated, carbondioxide and alkaline phosphatase were decreased in experimental rats. Other blood parameters were not changed significantly. Experimental rats lost weight and became anxious. Histopathological examination showed mononuclear inflammatory cell invasion in the portal areas, nuclear glycogen vacuoles in the parenchymal area, single-cell necrosis in a few foci, clear expansion in the central hepatic vein and sinusoids, hyperplasia in Kupffer cells and potential fibrous tissue expansion in the portal areas in the experimental rats. However, no considerable histologic damage was observed in the brain and kidney specimens. CONCLUSIONS: It can be concluded that H2S inhalation equivalent to pathologic halitosis producing level in humans may lead to systemic effects, particularly heart or liver damage in rats.

The evaluation of olfactory function in individuals with chronic halitosis.

Halitosis and olfactory dysfunction may disrupt an individual's quality of life remarkably. One may ask whether halitosis has effects on olfactory functions or not? Thus, the aim of this study was to evaluate the olfactory abilities of subjects with chronic halitosis evaluated using the measurements of volatile sulfur compounds. This study was carried out in 77 subjects, with a mean age of 40.1±13.3 years, ranging from 18 to 65 years. Forty-three participants were diagnosed as halitosis according to the gas chromatography results and constituted the halitosis group. Also, a control group was created from individuals without a complaint of halitosis and also who had normal values for volatile sulfur compounds. Each subject's orthonasal olfactory and retronasal olfactory functions were assessed using "Sniffin' Sticks" and retronasal olfactory testing. The results showed that odor threshold scores were lower in participants with halitosis compared with controls. Also, hyposmia was seen more common in the halitosis group than in controls. Moreover, a significant negative correlation was found between odor threshold scores and volatile sulfur compounds levels, particularly with hydrogen sulfide and dimethyl sulfide levels. The results suggest that the chronic presence of volatile sulfur compounds may have a negative effect on olfactory function.

Tongue coating: related factors.

AIM: A clear relationship between tongue coating and oral malodour has been observed in many clinical trials. Why or when this coating is formed remains an open question. The aim of this study was to analyse possible factors related to the presence of tongue coating in a population complaining from oral malodour. MATERIALS AND METHODS: Patients were recruited from a halitosis clinic (UZ Leuven). Medical history, dietary and oral hygiene habits were retrieved via a questionnaire. Data were recorded on organoleptic score and level of sulphur compounds in breath, anatomical features of the tongue dorsum, amount of tongue coating (according to three indices: Miyazaki, Winkel and modified Winkel), tongue coating wet weight and salivary flow. The correlation between the presence of tongue coating and a series of parameters was analysed. RESULTS: The level of oral hygiene was the strongest determinant factor for the presence of tongue coating. Smoking, presence of a denture, periodontal status and dietary habits also correlated although less obvious. CONCLUSION: The presence of tongue coating appears to be related to several factors of which oral hygiene is the strongest.

Comparative Evaluation of the Effects of Adenotonsillar Hypertrophy on Oral Health in Children.

We aimed to investigate the oral health of children in terms of the presence of dental caries, periodontal health, halitosis, and dentofacial changes in patients who had adenotonsillar hypertrophy related to mouth breathing and compared these findings with nasal breathing healthy and adenotonsillectomy-operated children. The patient group comprised 40 mouth-breathing children who were diagnosed with adenotonsillar hypertrophy, while the control group consisted of 40 nasal breathing children who had no adenotonsillar hypertrophy. Forty children who had undergone an adenotonsillectomy operation at least 1 year prior to the study were included in the treatment group. Oral examinations of all children were conducted, and the parents were asked about medical and dental anamnesis, demographic parameters, toothbrushing and nutrition habits, oral health-related quality of life (OHRQoL), and symptoms of their children. Demographic parameters, toothbrushing and nutrition habits, and the presence of bad oral habits did not differ between groups (p > 0.05). Adenotonsillectomy is associated with a remarkable improvement in symptoms; however, some symptoms persist in a small number of children. The salivary flow rate, dmft/s, DMFT/S index, plaque, and gingival index scores did not differ between groups (p > 0.05). The patient group showed higher rates of halitosis when compared with the treatment and control groups (p < 0.001). Mouth breathing due to adenotonsillar hypertrophy caused various dentofacial changes and an increase in Class II division 1 malocclusion (p < 0.001). It was shown that adenotonsillar hypertrophy does not negatively affect OHRQoL, it could be a risk factor for dental caries, periodontal diseases, and halitosis, but by ensuring adequate oral health care, it is possible to maintain oral health in children with adenotonsillar hypertrophy. Also, it is recommended that orthodontic treatment should start as soon as possible if it is required. In this context, otorhinolaryngologists, pedodontists, and orthodontists should work as a team in the treatment of children with adenotonsillar hypertrophy.

A digital tongue imaging system for tongue coating evaluation in patients with oral malodour.

OBJECTIVE: Several simple visual methods have been developed for assessing tongue coating, but it is difficult to eliminate biases associated with these. The digital tongue imaging system (DTIS) was designed to acquire tongue surface images using a digital camera under controlled conditions, and to calculate tongue coating area. The aim of this study was to evaluate the potential of DTIS for clinical use by comparing it with the Winkel tongue coating index (WTCI). MATERIALS AND METHODS: Forty participants with oral malodour were rated on WTCI by two independent examiners, and photographs of their tongues were assessed using the DTIS. The photographs were also rated by the examiners (blinded to in vivo WTCI and DTIS statuses). RESULTS: Agreements between in vivo WTCI ratings and DTIS assessments were relatively high at r = 0.561 for one examiner and r = 0.736 for the other (P < 0.01), while agreements between the in vivo WTCI ratings and tongue photograph-based ratings were also high at r = 0.645 for one examiner and r = 0.742 (P < 0.01) for the other. CONCLUSIONS: Digital tongue imaging system was found to be highly reliable and as having potential clinical applications. However, the algorithm for determining in vivo tongue coating status requires improvement.

Halitosis associated volatiles in breath of healthy subjects.

BACKGROUND: Halitosis can have an intra- or extra-oral origin. In all cases, bad breath is caused by the presence of volatile organic compounds originating from the mouth or the expired air. They can be specific for certain diseases or infections. STUDY OBJECTIVE: This study explored the presence and concentration of these volatile compounds normally associated with halitosis in the breath of healthy symptomless volunteers. METHODS: Alveolar and mouth air of 40 healthy volunteers as well as environmental air were analyzed by gas chromatography-mass spectrometry (GC-MS) and by a commercially available GC device (OralChroma). RESULTS: 14 compounds, associated with halitosis could be detected. All of them except carbon disulfide, appeared to be (partly) produced endogenously and/or in the mouth. Acetone, 2-butanone, 2-pentanone and 1-propanol were common to all volunteers in both alveolar and mouth air and indole and dimethyl selenide in alveolar air. CONCLUSIONS: GC-MS seems a promising tool for differential diagnosis of halitosis, with the possibility to detect extra-oral causes, which often remain undetected unless characterized by a specific smell.

Drug-related oral malodour (halitosis): a literature review.

Dry mouth (xerostomia), is a fairly common, well-researched condition, which is an indirect cause of oral malodour. This systematic literature review looked into another cause of bad breath: adverse drug reactions in the orofacial region causing halitosis. The study focused on extraoral halitosis, and its subdivisions, particularly blood borne halitosis in which malodourous compounds in the blood stream are carried to the lungs, passively diffused across the pulmonary alveolar membrane to enter the breath. An electronic search was conducted in various databases. Inclusion criteria were: editorials, case control studies, retrospective studies and randomized double-blind studies published in English between 1983 and March 2017. The search identified a total of 23 articles. According to these, drug-related halitosis may be caused by nine medications. Dimethyl sulfoxide, cysteamine and suplatast tosilate are metabolised to dimethyl sulfide, a malodourous compound that is stable in blood and is transported into the breath. Disulfiram is reduced to carbon disulfide, also a stable compound in blood. Nitric oxide reacts with foul-smelling volatile organosulfur compounds. The degradation of penicillamine raises the pH level, favouring the growth of gram-negative bacteria in the oral cavity producing halitosis. Chloral hydrate, phenothiazine, and paraldehyde could not be related to halitosis. The analysis showed that halitosis can be caused by medication but does not correlate to any specific disease or specific form of drug therapy. The pharmacological compounds identified as causes of halitosis are administered to treat a broad spectrum of diseases, or in therapeutic regimes.

Dimethylsulphidemia: the significance of dimethyl sulphide in extra-oral, blood borne halitosis.

Halitosis is a symptom and not a diagnosis. Rather, the topic represents a spectrum of disorders, including intra-oral, otorhinolaryngological, metabolic, systemic, pulmonary, psychological and neurological conditions. Halitosis may be the third most common trigger for patients to seek dental care and can cause significant impact on patient quality of life. About 10% of all genuine halitosis cases are attributed to extra-oral processes. Some authorities have reported that the nasal cavity and the oropharynx are the most common sites of origin of extra-oral halitosis. However, recent evidence appears to suggest that blood borne halitosis may be the most common subtype of extra-oral halitosis. Tangerman and Winkel report that dimethyl sulphide was the main volatile implicated in extra-oral blood borne halitosis. They proposed a hitherto unknown metabolic condition by way of explanation for this finding, resulting in systemic presence of dimethyl sulphide in blood and alveolar breath. This paper reviews the knowledge base regarding the behaviour of dimethyl sulphide in physiological systems and those disorders in which blood borne halitosis secondary to dimethylsulphidemia is thought to have an aetiopathological role.

Halitosis: could it be more than mere bad breath?

Halitosis is a generic term used to describe unpleasant odor emanating from the mouth air and breath, independent of the source where the odor substances originate. It affects between 50 and 65% of the population, but despite its frequency, this problem is often unaccepted and declared as taboo. Ninety percent of patients suffering from halitosis have oral causes: a small, but important percentage, of oral malodor cases have an extra-oral etiology, very often falling into the category of "blood-borne halitosis". Several systemic diseases have been found to provoke malodor or to be a cofactor; bad breath may be an early sign of a serious local or systemic condition. A psychogenic halitosis also exists including the variant "pseudo-halitosis", when the oral malodor does not exist, but the patient believes he or she is suffering severely from it, and the halitophobia, when, instead, there is an exaggerated fear of having halitosis. The aims of this paper are to review both oral and extra-oral causes of halitosis, especially those related to underlying systemic diseases, and to provide the primary care clinician a helpful means for its diagnosis and management. In fact, it is important to determine quickly whether the odor comes from an oral cause or not: if so, it requires referral to a dentist; if not (extra-oral origin alone or combined), its management requires the treatment of the underlying causes. Extra-oral disorders can be the cause in up to 15% of cases.

No significant association between halitosis and upper gastrointestinal endoscopic findings: a prospective study.

BACKGROUND: Previous studies have focused on the relationship between halitosis, gastroesophageal reflux disease and Helicobacter pylori. In this study we aimed to investigate the interaction between halitosis and upper gastrointestinal endoscopic findings. METHODS: Patients who previously had dyspepsia and had undergone endoscopic examination were included in the study. Symptoms of dyspepsia were investigated by means of a questionnaire that investigated halitosis. Patients who suffered from objective halitosis (confirmed by questions both to the patient and their relatives) were further investigated. Patients with known local or systemic causes of halitosis or structural disorders at endoscopy were excluded. RESULTS: The study included 358 patients (121 men and 237 women) with dyspeptic symptoms. The patients with and without halitosis had mean ages of (39.4 ± 13.5) and (43.1 ± 14.9) years, respectively. Patients without halitosis were significantly older than those in the halitosis group (P < 0.05). Patients in the halitosis group had significantly higher frequencies of regurgitation, bloating and nausea (P < 0.05) when compared to patients without halitosis. Endoscopic findings, including esophagitis, open cardia, hiatal hernia, gastritis and duodenitis, were comparable in the two groups. CONCLUSIONS: The frequency of halitosis was high in patients with dyspepsia who underwent upper gastrointestinal endoscopy. Halitosis had a close relationship with several upper gastrointestinal symptoms, including regurgitation, nausea and bloating. There was no significant association between upper gastrointestinal endoscopic findings and halitosis.

Reduction of mouth malodour and volatile sulphur compounds in intensive care patients using an essential oil mouthwash.

The aim of this study was to explore the effect of an essential oil solution on levels of malodour and production of volatile sulphur compounds (VSC) in patients nursed in intensive care unit (ICU). Thirty two patients received 3 min of oral cleaning using an essential oil solution (mixture of tea tree, Melaleuca alternifolia, peppermint, Mentha piperita and lemon, Citrus limon) on the first day, and Tantum (benzydamine hydrochloride) on the second day. Two trained nurses measured the level of malodour with a 10 cm visual analogue scale (VAS) and VSC with a Halimeter before (Pre), 5 min after (Post I) and 1 h following treatment (Post II). The level of oral malodour was significantly different following the essential oil session, and differed significantly between two sessions at Post I (p < 0.005) and Post II (p < 0.001). Differences between the two sessions were significant (Tantum, p < 0.001; essential oil, p < 0.001) in the level of VSC and significantly lower in the essential oil session than Tantum at the Post II (p < 0.05). These findings suggest that mouth care using an essential oil mixture of diluted tea tree, peppermint and lemon may be an effective method to reduce malodour and VSC in intensive care unit patients.

Condiciones bucales y sistémicas asociadas a la halitosis genuina / Oral and systemic conditions associated with genuine halitosis

La Halitosis es definida como un olor desagradable u ofensivo que emite la cavidad bucal, usualmente tiene una causa bucal, particularmente derivada del metabolismo bacteriano sobre los sustratos y aminoácidos que contienen azufre. Durante mucho tiempo, fue concebida como una consecuencia de la enfermedad periodontal, hoy en día se sabe que, ocasionalmente el consumo de ciertos medicamentos, disfunciones metabólicas, respiratorias, hormonales y otras alteraciones sistémicas pudieran ser el factor etiológico del mal olor de la boca, por lo que el propósito de esta investigación es analizar las condiciones bucales y sistémicas asociadas a la halitosis genuina en los pacientes que acuden a los postgrado de Periodoncia, Prótesis y Endodoncia de la Facultad de Odontología de la Universidad Central de Venezuela (FdeOUCV) partir del sistema de registro organoléptico. 38 pacientes diagnosticados con halitosis, durante el período Marzo-Octubre 2010, fueron evaluados a partir de un consentimiento informado admitiendo su participación en el estudio, por medio de un cuestionario con una escala de medición de actitudes y respuestas, una historia de halitosis, un examen clínico para establecer la presencia o no de enfermedad periodontal, la valoración organoléptica en diversos lugares de la cavidad bucal (Rosenberg y Mc Culloch, 1992) y el índice de cubierta lingual (Winkel, 2003). El criterio de exclusión estaba determinado por la ingesta de antibióticos durante tres semanas previas al examen, no obstante ningún paciente fue excluido por esta situación. Se realizó el análisis cualitativo y cuantitativo respectivo. Se encontró una diferencia estadísticamente significativa p<0,1 en el grupo con salud periodontal con respecto al grupo con enfermedad periodontal, en los aspectos relacionados con la sensación de hambre, sequedad y mal gusto en la boca y en relación con actitudes específicas asociadas a eructos, alejarse de otras personas...

The halitosis usually has a oral cause, particularly derived from the bacterial metabolism on the substrates and amino acids that contain sulfur. During long time, it was conceived like a consequence of the periodontal disease, nowadays knows that, occasionally the metabolic, respiratory, hormonal medicine consumption certain, dysfunctions and other systemic alterations could badly be the etiological factor of the scent of the mouth, reason why the intention of this investigation is to analyze the oral and systemic conditions associated to the genuine halitosis in the patients who go to the Periodoncia, Prosthesis and Endodontic of the Faculty of Dentistry of the Central University of Venezuela (FDOUCV) from the system of organoleptic registry. 38 patients diagnosed with halitosis, during the period March-October 2010, were evaluated from an informed consent admitting their participation in the study, by means of a questionnaire with a scale of measurement of attitudes and answers, a history of halitosis, a clinical examination to establish the presence or not of periodontal disease, the organoleptic valuation in diverse places of the oral cavity (Rosenberg and Mc Culloch, 1992) and the index of lingual cover (Winkel, 2003). The exclusion criterion was determined by the antibiotic ingestion during three weeks previous to the examination, despite no patient was excluded by this situation. The qualitative and quantitative analysis was made. Was a statistically significant difference p< 0.1 in the group with respect to the group with periodontal disease, in the aspects related to the sensation of hunger, dryness and badly taste in the mouth and in relation to specific attitudes associated to belches, to move away of other people, oral breathing and ingestion of liquids and candies, as well as in the index of lingual cover degree eight (8)....

Clinical effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc-lactate on oral halitosis. A dual-center, double-blind placebo-controlled study.

OBJECTIVES: The aim of this double-blind, parallel study was to test the clinical efficacy of a newly developed mouthrinse in the treatment of oral halitosis in patients without periodontitis. MATERIAL AND METHODS: Forty volunteers, recruited in two centers, participated in this study. Patients were selected on the basis of (1) halitosis of oral origin, (2) full-mouth organoleptic score>1, using an arbitrary 0-5 scale, (3) level of volatile sulfur compounds (VSC)>170 parts per billion (ppb) and (4) Winkel tongue coating index (WTCI)>4 (0-12). Intervention included gargling with a mouthrinse containing chlorhexidine (0.05%), cetylpyridinium chloride (0.05%) and zinc-lactate (0.14%) or with a placebo mouthrinse without active ingredients. At days 0 and 14 clinical variables were assessed in order of performance: (1) organoleptic assessments, (2) levels of VSC, and (3) WTCI. RESULTS: Treatment with the active mouthrinse resulted in a significant mean reduction in the organoleptic score from 2.8 to 1.5 (p<0.005). In the placebo group, no significant reduction in the mean organoleptic score occurred. Consequently, this resulted, after 2 weeks, in a greater change of the organoleptic scores in the test group in comparison to the placebo group (p<0.005). The mean VSC scores were reduced from 292 to 172 ppb in the test group (p<0.005), whereas no reduction was observed in the placebo group. At the 2-week examination, the mean change of the VSC scores in the test group was significantly greater than the mean change in the placebo group (p<0.005). Neither in the test nor in the placebo group a significant reduction in tongue coating was observed. CONCLUSIONS: In conclusion, the tested mouthrinse is effective in the treatment of oral halitosis.

Halitosis: a review of basic principles

Halitosis, also known as bad breath or oral malodor, is the general term used to describe any disagreeable odor in expired air, regardless of whether the odorous substances originate from oral or non-oral sources. Bad breath can be detrimental to one’s self-image and confidence, causing social, emotional and psychological anxiety. This paper provides a comprehensive review of the historical background, prevalence, social aspects and pathological causes of halitosis as well as the dental professional’s responsibility.

Mau hálito está associado à dispepsia: estudo de associação e equivalência, e avaliação da validade dos métodos de diagnóstico da halitose / Bad breath is associated with dispepsy: a study on the association and equivalence, and validity evaluation methods for halitosis diagnosis

Tendo em vista, que a suspeita da presença de halitose, tem sido um dos motivos que leva pacientes com queixa de halitose a procurarem especialistas em gastroenterologia, ou mesmo a serem submetidos à endoscopia digestiva, exame invasivo e de custo elevado, é importante estabelecer quando um distúrbio digestivo orgânico ou funcional pode ser causador de halitose. Objetiva analisar se a dispepsia está associada à halitose ou se o mau hálito ocorre de forma equivalente em indivíduos com dispepsia e sem dispepsia; Acessar a validade dos métodos de diagnóstico de halitose. Todos os pacientes que se apresentaram no Departamento de Endoscopia do Hospital Universitário Pedro Ernesto da Universidade do Estado do Rio de Janeiro (1 de março de 2006 a 28 de fevereiro de 2007) e no Laboratório de Patologia Clínica do Hospital Universitário Gafrée Guinle da Universidade Federal do Estado do Rio de Janeiro (1 de janeiro de 2007 a 28 de fevereiro de 2007) foram convidados a participar do estudo. Aqueles que aceitaram participar da pesquisa assinaram o consentimento informado. A halitose foi mensurada através de avaliação organoléptica por um avaliador treinado (muito forte, forte, moderado, leve, ausente), Halímetro (INTERSCAN CORP) e entrevista com pessoa próxima. Todos os métodos de mensuração foram testados quanto a sua validade. O ponto de corte dos valores do Halímetro, acima do qual se considerou presença de halitose, foi baseado na análise da curva ROC em relação à avaliação organoléptica (140ppb, sensibilidade =62 por cento e especificidade = 93 por cento). No total, 814 pacientes avaliados durante o estudo, 311 foram selecionados para testar a associação e equivalência (critério de seleção: indivíduos em jejum de 12hs, avaliados no turno da manhã por um único avaliador) enquanto, 138 foram selecionados para avaliar a validade dos testes diagnósticos (critério de seleção: indivíduos em jejum de 12hs, avaliados por um mesmo avaliador e que vieram acompanhados de...